Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas.
Click "Analyze" to generate stock analysis
GNPX Price Trend and Signals
GNPX Financials
2025-10-28Bearishprice_signal
Large price change detected: -20.11%.
2025-10-23Bearishprice_signal
Large price change detected: -16.42%.
2025-10-21Somewhat Bullishprice_signal
Yearly high detected.
2025-10-21Bullishprice_signal
Large price change detected: 4007.14%.
2025-10-20Bearishprice_signal
Large price change detected: -22.22%.
2025-10-17Bearishprice_signal
Large price change detected: -25.0%.
2025-10-16Bearishprice_signal
Large price change detected: -42.86%.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-15Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-15Bullishprice_signal
Large price change detected: 236.0%.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.